Adagio Medical Holdings, Inc. (ADGM)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 90K 180K 270K Q2 '24: 254K Q4 '24: 137K Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q2 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

-1.5M -1M -500K 0 500K 1M 1.5M Q4 '23: -256K Q1 '24: -516K Q2 '24: -428K Q4 '24: -1.4M Q1 '25: -253K Q2 '25: -342K Q3 '25: -31K Q4 '25: -58K Q4 '23 Q1 '24 Q2 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q2 '24: -6.7M Q4 '24: -58.1M Q1 '25: -7.4M Q2 '25: -4.7M Q3 '25: -5.7M Q4 '25: -4M Q1 '26: -5.2M Q2 '26: -4.9M Q2 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '24: -8.2M Q4 '24: -57.4M Q1 '25: -7.7M Q2 '25: -3.9M Q3 '25: -10.1M Q4 '25: -3.3M Q1 '26: -7M Q2 '26: -6.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 600K 1.2M 1.8M Q4 '23: 334K Q1 '24: 542K Q2 '24: 682K Q4 '24: 1.5M Q1 '25: 253K Q2 '25: 342K Q3 '25: 31K Q4 '25: 58K Q4 '23 Q1 '24 Q2 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25

Operating Cash Flow Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q2 '24: -6.9M Q4 '24: -7.1M Q1 '25: -7.2M Q2 '25: -4.7M Q3 '25: -3M Q4 '25: -4.1M Q1 '26: -4.1M Q2 '26: -5.3M Q2 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-9M -6M -3M 0 3M 6M 9M Q1 '24: -6.9M Q2 '24: -7.1M Q4 '24: -7.8M Q1 '25: -7.5M Q2 '25: -4.7M Q3 '25: -3.5M Q1 '26: -4.1M Q2 '26: -5.3M Q1 '24 Q2 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 8M 16M 24M Q1 '24: 779.9K Q2 '24: 779.9K Q3 '24: 987.8K Q1 '25: 15.4M Q2 '25: 15.4M Q3 '25: 15.4M Q1 '26: 22.2M Q2 '26: 22.2M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-45.00 -30.00 -15.00 0.00 15.00 30.00 45.00 Q3 '24: -37.30 Q4 '24: -29.69 Q1 '25: -19.92 Q2 '25: -12.92 Q3 '25: -5.24 Q4 '25: -1.61 Q1 '26: -1.41 Q2 '26: -1.36 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.